Floatz logo

METHADONE

Hydromorphone Use

Rutgers, The State University of New JerseySmall moleculePhase 4 / ApprovedActive
BBB
78/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

23 Active assets in the Hydromorphone Use cohort.

View all 28

Same molecule, other indications

METHADONE is also rated in:

chronic pain syndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Opiate AddictionDormant
BBB
Indicative ·
73 / 100
View asset →
Chronic PainDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →